Chaomin Li

Title: The Innovations of Inventor Chaomin Li in Biotechnology

Introduction: Chaomin Li, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of biotechnology. With a focus on pharmaceutical innovations, he is known for his inventive work on Bruton's tyrosine kinase inhibitors.

Latest Patents: Li holds a patent for "Crystalline polymorphs of Bruton's tyrosine kinase inhibitors." This patent outlines the crystalline forms of (R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide, including the pharmaceutical compositions, methods of use, and methods of making these compounds.

Career Highlights: Chaomin Li is currently employed at Biogen MA Inc., a prominent biotechnology company focused on the development of therapies for neurological diseases. His innovative research has the potential to significantly impact treatment options for patients.

Collaborations: Throughout his career, Li has collaborated with esteemed colleagues such as Fengmei Zheng and Anton Peterson. These partnerships have further enriched his contributions to the field and advanced their shared goals in medical innovation.

Conclusion: Chaomin Li exemplifies the spirit of innovation within the biotechnology sector. His work on Bruton's tyrosine kinase inhibitors showcases his commitment to developing effective pharmaceutical solutions, making him a notable inventor in today's research landscape.